Bangladesh, July 3 -- Altogether 1,000 scientists and researchers from all over the world agreed on the need for more trials to test antivirals, immunomodulatory drugs and anti-thrombotic agents, as well as combination therapies, at different stages of Covid-19 disease.

They came to this agreement at two half-day virtual summit on July 1 and 2, organised by the World Health Organization (WHO), said a press release.

The researchers and scientists came together on a global platform to track the progress of Covid-19 Research and Development (R&D).

The virtual meeting analysed 15 vaccine trial designs from different developers, and criteria for conducting robust trials to assess safety and efficacy of vaccine candidates.

Participants disc...